EP3702351
Samsetning sem inniheldur MEK hindra
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
18.10.2013EP published:
22.11.2023EP application number:
19211405.6
EP translation filed:
29.1.2024Grant published:
15.2.2024EPO information:
European Patent Register
Max expiry date:
17.10.2033Expiry date:
17.10.2026Next due date:
31.10.2026
Title in English:
FORMULATION COMPRISING A MEK INHIBITORLanguage of the patent:
English
Timeline
Today
18.10.2013EP application
22.11.2023EP Publication
29.1.2024Translation submitted
15.2.2024Registration published
17.10.2026Expires
Owner
Name:
Array Biopharma, Inc.Address:
3200 Walnut Street, Boulder, CO 80301, US
Inventor
Name:
KRELL, Christoph, MaxAddress:
4054 Basel, CH
Name:
MISUN, MarianAddress:
79418 Schliengen, DE
Name:
NIEDERER, Daniel, AndreasAddress:
4104 Oberwil, CH
Name:
PACHINGER, Werner, HeinzAddress:
4057 Basel, CH
Name:
WOLF, Marie-ChristineAddress:
68300 St. Louis, FR
Name:
ZIMMERMANN, DanielAddress:
4056 Basel, CH
Name:
LIU, WeidongAddress:
Boulder, CO 80301, US
Name:
STENGEL, Peter, J.Address:
Boulder, CO 80301, US
Name:
NICHOLS, PaulAddress:
West Lafayette, IN 47906, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201261716169 PDate:
19.10.2012Country:
US
Classification
Categories:
C07D 235/06, A61K 31/4184, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 12
Paid: 8.10.2024
Expires: 17.10.2025
Payer: Árnason Faktor ehf.
Number: 13
Paid: 8.10.2025
Expires: 17.10.2026
Payer: Árnason Faktor ehf.